WuXi Biologics (Cayman)
(OTC) WXXWY
WuXi Biologics (Cayman) Financials at a Glance
Market Cap
$18.77B
Revenue (TTM)
CN¥40.25B
Net Income (TTM)
CN¥8.22B
EPS (TTM)
$0.32
P/E Ratio
27.07
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$9.06
Volume
30,043
Open
$9.06
Price
$9.06
Volume
30,043
Open
$9.06
Previous Close
$9.06
Daily Range
$8.87 - $9.15
52-Week Range
$6.20 - $11.21
Estimated Earnings Date
Aug 26, 2026
Dividend
$0.00
Beta (Volatility)
0.93 (Low)
Price
$9.06
Volume
30,043
Open
$9.06
Previous Close
$9.06
Daily Range
$8.87 - $9.15
52-Week Range
$6.20 - $11.21
Estimated Earnings Date
Aug 26, 2026
WXXWY News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout WuXi Biologics (Cayman)
Industry
Life Sciences Tools and Services
Sector
Health CareEmployees
13,252
CEO
Zhi Sheng Chen, PhD
Website
www.wuxibiologics.comHeadquarters
Wuxi, 214092, CN
WXXWY Financials
Key Financial Metrics (TTM)
Gross Margin
45.98%
Operating Margin
30.47%
Net Income Margin
22.53%
Return on Equity
10.64%
Return on Capital
12.83%
Return on Assets
7.70%
Earnings Yield
3.69%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$18.77B
Shares Outstanding
2.07B
Volume
30.04K
Avg. Volume
79.89K
Financials (TTM)
Gross Profit
CN¥17.56B
Operating Income
CN¥11.55B
EBITDA
CN¥14.50B
Operating Cash Flow
CN¥10.07B
Capital Expenditure
-CN¥5.99B
Free Cash Flow
CN¥4.08B
Cash & ST Invst.
CN¥15.75B
Total Debt
CN¥3.11B
WuXi Biologics (Cayman) Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
CN¥11.62B
+36.0%
Gross Profit
CN¥5.66B
+73.2%
Gross Margin
48.71%
N/A
Market Cap
$18.77B
N/A
Market Cap/Employee
$1.49M
N/A
Employees
12,575
N/A
Net Income
CN¥2.52B
+122.6%
EBITDA
CN¥4.72B
+108.2%
Quarterly Fundamentals
Total Cash
CN¥15.75B
+40.1%
Total Debt
CN¥3.11B
-31.9%
Accounts Receivable
CN¥8.90B
+43.9%
Inventory
CN¥1.44B
-18.4%
Long Term Debt
CN¥1.85B
-51.7%
Short Term Debt
CN¥1.26B
+71.7%
Return on Assets
7.70%
N/A
Return on Invested Capital
11.98%
N/A
Free Cash Flow
CN¥2.79B
+1174.1%
Operating Cash Flow
CN¥4.59B
+96.6%